March 2026
1. ACKER F, Wenger K, Reck M, Waller CF, et al
   Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315).
   Int J Cancer. 2026 Mar 23. doi: 10.1002/ijc.70456.
   

   >> Share

   
   
2. GUTZMER R, Weichenthal M, Eigentler T, Mohr P, et al
   Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.
   Int J Cancer. 2026 Mar 15. doi: 10.1002/ijc.70440.
   

   >> Share

   
   
3. GAO M, Zang H, Zhao W, Zhou Y, et al
   Unraveling glymphatic disruption in brain tumors: Insights from perivascular space network analysis.
   Int J Cancer. 2026 Mar 7. doi: 10.1002/ijc.70441.
   

   >> Share

   
   
4. ZHAO J, Li T, Jing Y, Yang H, et al
   Regulation of endoplasmic reticulum-mitochondria transfer and its importance in GBM.
   Int J Cancer. 2026;158:1166-1177.
   

   >> Share

   
   February 2026
5. WELLER J, Katzendobler S, Thiele F, Riesberg A, et al
   Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer.
   Int J Cancer. 2026 Feb 25. doi: 10.1002/ijc.70407.
   

   >> Share

   
   December 2025
6. MUELLER T, Vasella F, Velz J, Voglis S, et al
   Conditional survival in glioblastoma: The evolution of prognostic factors over time.
   Int J Cancer. 2025 Dec 30. doi: 10.1002/ijc.70285.
   

   >> Share

   
   
7. GUELEN MS, Ferdowssian K, Jung N, Celik HN, et al
   Outcomes and risk factors of hemorrhage in patients with resected brain metastases.
   Int J Cancer. 2025 Dec 7. doi: 10.1002/ijc.70250.
   

   >> Share

   
   November 2025
8. VAN DEN ENDE B, de Smet F, Jacobs S, Coosemans A, et al
   Advances in preclinical models for pediatric diffuse intrinsic pontine glioma.
   Int J Cancer. 2025 Nov 30. doi: 10.1002/ijc.70275.
   

   >> Share

   
   October 2025
9. ALHALABI OT, Klein L, Wasilewski D, Mellal A, et al
   Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis.
   Int J Cancer. 2025;157:1613-1624.
   

   >> Share

   
   September 2025
10. HONIKL LS, Kelm A, Krieg SM, Meyer B, et al
    Prospective inter-individual analysis of quality-adjusted life years (QALYs) in brain tumor patients: A comprehensive assessment of health preferences.
    Int J Cancer. 2025 Sep 25. doi: 10.1002/ijc.70171.
    

    >> Share

    
    
11. SAEEDI E, Nemati S, Lotfi F, Domingues A, et al
    IRANCANSURV: A comprehensive analysis of childhood cancer survival in Iran.
    Int J Cancer. 2025 Sep 1. doi: 10.1002/ijc.70100.
    

    >> Share

    
    August 2025
12. SIGEL B, Withrow DR, Veiga LHS, Saito E, et al
    Adult brain cancer incidence patterns: A comparative study between Japan and Japanese Americans.
    Int J Cancer. 2025;157:436-444.
    

    >> Share

    
    July 2025
13. GALLUZZO A, Maffezzini M, Fumagalli ML, Sambruni I, et al
    The anti-aging Klotho protects glioblastoma macrophages from radiotherapy-induced inflammation and predicts immunotherapy response.
    Int J Cancer. 2025 Jul 21. doi: 10.1002/ijc.70038.
    

    >> Share

    
    June 2025
14. MEULENDIJKS TFC, Kaspers GJL, Ramaswamy V, Tsang DS, et al
    How long should survivors of pediatric medulloblastoma and ependymoma be screened for recurrence? A retrospective cohort study.
    Int J Cancer. 2025 Jun 23. doi: 10.1002/ijc.70016.
    

    >> Share

    
    
15. HEMMINGSEN CH, Kjaer SK, Hjorth S, Norby U, et al
    Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35509.
    

    >> Share

    
    
16. ABUHAMED J, Nikkila A, Raitanen J, Lohi O, et al
    Risk of childhood brain tumors after exposure to CT radiation: A nationwide population-based case-control study in Finland.
    Int J Cancer. 2025;156:2148-2157.
    

    >> Share

    
    April 2025
17. XIE Y, Fang H, Cheng W, Xu T, et al
    Furmonertinib in uncommon EGFR-mutated non-small cell lung cancer with central nervous system metastases: A retrospective cohort study.
    Int J Cancer. 2025 Apr 29. doi: 10.1002/ijc.35460.
    

    >> Share

    
    
18. CHELLADURAI M, Sagi-Assif O, Ben-Menachem S, Meshel T, et al
    A heterodimer of hemoglobin identifies theranostic targets on brain-metastasizing melanoma cells.
    Int J Cancer. 2025 Apr 26. doi: 10.1002/ijc.35458.
    

    >> Share

    
    
19. LARROQUETTE M, Bronnimann C, Ollivier M, Daubon T, et al
    Carboplatin-gemcitabine for refractory high-grade meningiomas: A study from the French national OMEGA consortium.
    Int J Cancer. 2025 Apr 21. doi: 10.1002/ijc.35453.
    

    >> Share

    
    
20. CHOULEUR T, Etchegaray C, Villain L, Lesur A, et al
    A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.
    Int J Cancer. 2025 Apr 11. doi: 10.1002/ijc.35441.
    

    >> Share

    
    
21. HUANG T, Wu D, Jiang L, Wu Z, et al
    Neuro-astrocytic network in breast cancer brain metastases: Adaptive mechanisms and novel therapeutic targets.
    Int J Cancer. 2025 Apr 1. doi: 10.1002/ijc.35421.
    

    >> Share

    
    December 2024
22. CHENG S, McLaughlin JR, Brown MC, Rutka J, et al
    Birth characteristics and the risk of childhood brain tumors: A case-control study in Ontario, Canada.
    Int J Cancer. 2024 Dec 13. doi: 10.1002/ijc.35287.
    

    >> Share

    
    October 2024
23. 
    Expression of Concern: Betulinic Acid: A New Cytotoxic Agent Against Malignant Brain-tumor Cells.
    Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35236.
    

    >> Share

    
    
24. HUANGFU L, Zha B, Li P, Wang L, et al
    A phase I clinical trial of sonodynamic therapy combined with radiotherapy for brainstem gliomas.
    Int J Cancer. 2024 Oct 8. doi: 10.1002/ijc.35218.
    

    >> Share

    
    September 2024
25. TURUBAN M, Kromhout H, Vila J, Vallbona-Vistos M, et al
    Occupational exposure to radiofrequency electromagnetic fields and brain tumor risk: Application of the INTEROCC job-exposure matrix.
    Int J Cancer. 2024 Sep 20. doi: 10.1002/ijc.35182.
    

    >> Share

    
    
26. EHRET F, Ruess D, Blanck O, Fichte S, et al
    Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis.
    Int J Cancer. 2024;155:916-924.
    

    >> Share

    
    July 2024
27. 
    Expression of Concern: HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
    Int J Cancer. 2024 Jul 25. doi: 10.1002/ijc.35119.
    

    >> Share

    
    
28. ZHANG Q, Chen K, Yu X, Fan Y, et al
    Spotlight on the treatment of non-small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives.
    Int J Cancer. 2024 Jul 3. doi: 10.1002/ijc.35070.
    

    >> Share

    
    
29. REN P, Bao H, Wang S, Wang Y, et al
    Multi-scale brain attributes contribute to the distribution of diffuse glioma subtypes.
    Int J Cancer. 2024 Jul 1. doi: 10.1002/ijc.35068.
    

    >> Share

    
    June 2024
30. KNABBE J, Kowalski T, Seliger C
    Pharmacological treatment of depression in patients with brain tumors.
    Int J Cancer. 2024 Jun 28. doi: 10.1002/ijc.35058.
    

    >> Share

    
    
31. GANSER K, Stransky N, Abed T, Quintanilla-Martinez L, et al
    K(Ca) channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K(Ca) expression levels.
    Int J Cancer. 2024 Jun 27. doi: 10.1002/ijc.35064.
    

    >> Share

    
    
32. 
    Correction to "Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells".
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35045.
    

    >> Share

    
    May 2024
33. 
    Correction to "Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus".
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35002.
    

    >> Share

    
    
34. 
    Expression of Concern: Nusrat Jahan, Jae M. Lee, Khalid Shah, Hiroaki Wakimoto (2017), Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. Int. J. Cancer, 141: 16
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35032.
    

    >> Share

    
    
35. MEENA D, Jha S
    Autophagy in glioblastoma: A mechanistic perspective.
    Int J Cancer. 2024 May 8. doi: 10.1002/ijc.34991.
    

    >> Share

    
    
36. DERKS SHAE, van der Meer EL, Joosse A, de Jonge MJA, et al
    The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
    Int J Cancer. 2024 May 4. doi: 10.1002/ijc.34984.
    

    >> Share

    
    April 2024
37. WEIJERS DD, Hirsch S, Bakhuizen JJ, van Engelen N, et al
    Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
    Int J Cancer. 2024;154:1455-1463.
    

    >> Share

    
    
38. O'NEILL K, Syed N, Crook T, Dubey S, et al
    Profiling of circulating glial cells for accurate blood-based diagnosis of glial malignancies.
    Int J Cancer. 2024;154:1298-1308.
    

    >> Share

    
    February 2024
39. XI S, Jiang S, Li H, Huang Q, et al
    Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
    Int J Cancer. 2024 Feb 27. doi: 10.1002/ijc.34854.
    

    >> Share

    
    
40. CHELLADURAI M, Xu D, Izraely S, Ben-Menachem S, et al
    A heterodimer of alpha and beta hemoglobin chains functions as an innate anticancer agent.
    Int J Cancer. 2024;154:561-572.
    

    >> Share

    
    January 2024
41. KEMMOTSU N, Ninomiya K, Kunimasa K, Ishino T, et al
    Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.
    Int J Cancer. 2024;154:169-179.
    

    >> Share

    
    
42. HOANG TT, Schraw JM, Peckham-Gregory EC, Scheurer ME, et al
    Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37 000 controls.
    Int J Cancer. 2024;154:41-52.
    

    >> Share

    
    December 2023
43. MENTIS AA, Papavassiliou KA, Piperi C, Papavassiliou AG, et al
    How can cancer research be illuminated by brain research (and vice versa)?
    Int J Cancer. 2023;153:1967-1970.
    

    >> Share

    
    October 2023
44. LARSEN PA, Amidi A, Ghith N, Winther JF, et al
    Quality of life of adolescent and adult survivors of childhood cancer in Europe-A systematic review.
    Int J Cancer. 2023;153:1356-1375.
    

    >> Share

    
    September 2023
45. SIRIRUNGREUNG A, Hansen J, Ritz B, Heck JE, et al
    Association between medically diagnosed postnatal infection and childhood cancers: A matched case-control study in Denmark, 1978 to 2016.
    Int J Cancer. 2023;153:994-1002.
    

    >> Share

    
    July 2023
46. PROKOP G, Wiestler B, Hieber D, Withake F, et al
    Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastoma.
    Int J Cancer. 2023 Jul 28. doi: 10.1002/ijc.34665.
    

    >> Share

    
    June 2023
47. GIELNIEWSKI B, Poleszak K, Roura AJ, Szadkowska P, et al
    Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma.
    Int J Cancer. 2023 Jun 20. doi: 10.1002/ijc.34631.
    

    >> Share

    
    
48. TSAKONAS G, Ekman S, Koulouris A, Adderley H, et al
    Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis.
    Int J Cancer. 2023 Jun 19. doi: 10.1002/ijc.34628.
    

    >> Share

    
    
49. WEISS S, Thomale UW, Schulz M, Kandels D, et al
    Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
    Int J Cancer. 2023 Jun 1. doi: 10.1002/ijc.34615.
    

    >> Share

    
    May 2023
50. ESLIN D, Zage PE, Bergendahl G, Lewis E, et al
    A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
    Int J Cancer. 2023 May 29. doi: 10.1002/ijc.34569.
    

    >> Share

    
    
51. OFEK P, Yeini E, Arad G, Danilevsky A, et al
    Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
    Int J Cancer. 2023 May 4. doi: 10.1002/ijc.34545.
    

    >> Share

    
    April 2023
52. KANNAN S, Cheng VWT
    Nanoparticle drug delivery to target breast cancer brain metastasis: Current and future trends.
    Int J Cancer. 2023 Apr 25. doi: 10.1002/ijc.34542.
    

    >> Share

    
    March 2023
53. BAO H, Ren P, Liang P, Liang X, et al
    Reply to: Comments on "New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction".
    Int J Cancer. 2023 Mar 17. doi: 10.1002/ijc.34514.
    

    >> Share

    
    
54. SABOUR S, Ghassemi F
    Comments on "New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction".
    Int J Cancer. 2023 Mar 17. doi: 10.1002/ijc.34515.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share